Do elevated neutrophils and monocytes reflect low-grade innate immune activation and higher vascular or endocrine risk?

Innate immune activation and myeloid dynamics

• Persistently elevated or high-normal circulating neutrophil and monocyte counts reflect chronic, low-grade innate immune activation. Under chronic systemic inflammatory stress, low-level cytokines drive biased, demand-adapted myelopoiesis in the bone marrow, skewing hematopoietic stem cell differentiation toward myeloid lineages.
• This process is reinforced by trained immunity, where epigenetic and metabolic reprogramming of myeloid progenitors yields hyper-responsive peripheral monocytes and neutrophils that display amplified pro-inflammatory behaviors.

Mechanistic pathways of cytokine propagation

• Once in circulation, these primed myeloid cells infiltrate vascular walls and key tissues, maintaining a self-reinforcing inflammatory loop (metaflammation).
• They continuously secrete vital mediators, including macrophage colony-stimulating factor (M-CSF), interleukin-1 beta (IL-1$\beta$), tumor necrosis factor-alpha (TNF-$\alpha$), and interleukin-6 (IL-6).

Vascular and endocrine risk pathology

• Mechanistic and Mendelian randomization studies establish that genetically proxied elevations in M-CSF and the IL-1 axis causally drive cardiovascular diseases, such as coronary artery disease and heart failure.
• Simultaneously, myeloid-derived TNF-$\alpha$, IL-1$\beta$, and IL-6 activate JNK and NF-$\kappa$B pathways within adipocytes, skeletal muscle, and the liver, directly disrupting insulin receptor signaling to promote insulin resistance, dyslipidemia, and type 2 diabetes.

Bottom line

• Elevated neutrophils and monocytes serve as reliable peripheral biomarkers and active drivers of a self-sustaining cytokine loop that directly promotes progressive cardiovascular pathology and systemic metabolic dysfunction.